Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

University, Company Employ AI for Anti-Aging Drugs

The medical analytics company Insilico Medicine is partnering with a university in Denmark to apply artificial intelligence to find new treatments for diseases associated with early aging. . . . → Read More: University, Company Employ AI for Anti-Aging Drugs

Gene Editing, Therapy Company Gains $83.5M in Venture Funds

A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round. . . . → Read More: Gene Editing, Therapy Company Gains $83.5M in Venture Funds

Life Science Execs: Financial, IP Info Top Hacker Targets

Technology executives at pharmaceutical and medical device enterprises in the U.S. say financial and intellectual property assets are their top targets for hackers, according to survey results released today. . . . → Read More: Life Science Execs: Financial, IP Info Top Hacker Targets

RNA Vaccine for Rabies Found Safe, Generates Antibodies

A vaccine to prevent rabies made from messenger RNA, genetic material transcribed from DNA, was shown in a clinical trial to be generally safe and able under some conditions to induce antibodies. . . . → Read More: RNA Vaccine for Rabies Found Safe, Generates Antibodies

Tough Ingested Hydrogels Designed for Long-Term Drugs

A medical engineering team developed and tested in animals a new water-based polymer material to deliver drugs for long-term release in the stomach. . . . → Read More: Tough Ingested Hydrogels Designed for Long-Term Drugs

Faster Process Devised for Targeted Antibodies

Researchers in the U.S. and U.K. designed techniques for quickly generating highly targeted antibodies in the lab, which can speed production of new vaccines and therapies. . . . → Read More: Faster Process Devised for Targeted Antibodies

Lilly Licensing Autoimmune Therapy in $400M Deal

Drug maker Eli Lilly and Company is licensing a therapy from a biotechnology company that produces self-correcting cells for people with disorders caused by a malfunctioning immune system. . . . → Read More: Lilly Licensing Autoimmune Therapy in $400M Deal

Calif. Agency Supporting Late Stem Cell Trial for ALS

California’s agency supporting stem cell research for regenerative medicine is helping fund a clinical trial testing stem cell treatments for amyotrophic lateral sclerosis, or ALS. . . . → Read More: Calif. Agency Supporting Late Stem Cell Trial for ALS

Stem Cell Clinics Found Marketing in ClinicalTrials.gov

A review of entries in the U.S. government’s clinical trial registry shows commercial stem cell clinics are using the respected database to promote their services. . . . → Read More: Stem Cell Clinics Found Marketing in ClinicalTrials.gov

Biotech Licensing Viral T-Cell Immunotherapies

A company making treatments for viral infections that stimulate natural T-cells in the immune system is licensing a related technology from Baylor College of Medicine. . . . → Read More: Biotech Licensing Viral T-Cell Immunotherapies